Delivery Order SPE2DB25D3404-SPE2DB25FUMQA

Award Date 3/21/25
Potential Completion Date 4/11/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $2,343.59 and a completion date of January 7, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with...
This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), with an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered with the System for Award Management (SAM.gov). The contract has a ceiling value of $2,265.29 and an ultimate completion date of May 16, 2024. It is a delivery order contract with a firm fixed price pricing type....
This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $4,530.60 firm fixed-price delivery order has an ultimate completion date of September 3, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award is for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML" and was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $9,374.36 with a firm fixed price and a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs...
This federal contract award is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a ceiling value of $7,030.77 and a completion date of December 30, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $4,687.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $4,687.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, and has a completion date of February 18, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract does not have a set-aside designation, indicating open...
This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,343.59 firm fixed price delivery order contract has a completion date of January 8, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This contract award to AmerisourceBergen Drug Corp. is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The award, valued at $9,061.20, was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 30, 2024. The contract is a delivery order and utilizes a firm fixed-price pricing type. This award does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMQA
    Delivery Order

This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a ceiling value of $4,687.18. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 11, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/21/25, 9:54 AM